Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
New evidence

Higher olive oil consumption tied to 13–22% lower diabetes risk in a first-of-its-kind meta-analysis — but the finding rests on limited studies and may not generalize beyond Europeans.

This is the first meta-analysis to systematically link olive oil to diabetes risk, but with few underlying studies and a focus on European clinical populations, the result is an early signal — not a settled fact.

Researchers combined data from cohort studies and randomized trials and found that people who consumed more olive oil had a 13–22% lower risk of developing diabetes. The benefit was particularly pronounced in European populations and with extra virgin olive oil. Because this is among the first pooled analyses on the topic, the findings should be viewed as preliminary until replicated in broader populations.

Where this fits in the evidence

This is among the first studies we've indexed on Olive Oil for Reduced Diabetes Risk — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top